This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
| identifier | question |
|---|---|
| cord-017948-fqhl1qb4 | Emerging infectious disease agents and their potential threat to transfusion safety Detection of prion infection in variant Creutzfeldt- Jakob disease: a blood- based assay Threat of dengue to blood safety in dengue- endemic countries PCR detection of nearly any dengue virus strain using a highly sensitive primer cocktail Do babesiosis and malaria share a common disease process? |
| cord-026021-b8vtmr9h | Philadelphia: JB Lippincott Where to get blood donors? |
| cord-016248-dxk0i6t7 | How low can you go? |
| cord-016871-1mlamf20 | A comparison of fi brinogen measurement methods with fi brin clot elasticity assessed by thromboelastometry, before and after administration of fi brinogen concentrate in cardiac surgery patients Can the use of thromboelastography predict and decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery? |
| cord-278174-znc99yos | Is a recalled unit of plasma being thawed in the waterbath? |
| cord-015941-4fz79wzf | Comparison of a commercial IgM capture ELISA with dengue antigen focus reduction microneutralization test and the centers for disease control dengue IgM capture- ELISA PCR detection of nearly any dengue virus strain using a highly sensitive primer cocktail Do babesiosis and malaria share a common disease process? |
| cord-261788-f728j3bb | What is your diagnosis? |
| cord-252273-mykwzlsu | WHO Timeline- COVID-19 COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| cord-217663-3g2j9tnk | Can We Be Certain that Storage Duration of Transfused Red Blood Cells Does Not Affect Patient Outcomes? |
| cord-217663-3g2j9tnk | When One Will Do? |
| cord-294241-11abmmyl | Basic Principles and Practice Mollison's Blood Transfusion in Clinical Medicine, 11th edn Global Perspectives in Transfusion Medicine Gift or good? |
| cord-281990-x5nql0cw | Blood Group Antigens and the Red Cell Membrane Influence Human Immunodeficiency Virus Infection? |
| cord-294585-dl5v9p50 | the development of haemophilia A therapeutics-from whole blood transfusion to recombinant DNA to gene therapy Sterilization of hepatitis and HTLV- III viruses by exposure to tri( n- butyl) phosphate and sodium cholate Current status of solvent/ detergenttreated frozen plasma Venous thromboembolism associated with the management of acute thrombotic thrombocytopenic purpura A process for solvent/ detergent treatment of plasma for transfusion at blood centers using a disposable bag system Removal of small non- enveloped viruses by nanofiltration Virus inactivation in blood components by photoactive phenothiazine dyes Methylene blue treated fresh- frozen plasma: what is its contribution to blood safety? |
| cord-003974-cr6omr9l | : How do we … integrate pathogen reduced platelets into our hospital blood bank inventory? |
| cord-003974-cr6omr9l | A retrospective evaluation of the hemostatic efficacy of pathogen reduced( PR) vs conventional( CONV) platelets at an academic medical center Transfusion reaction rates of pathogen reduced( PR) vs conventional( CONV) platelets in adults: a single academic center experience Activation status of pathogen reduced platelet components in plasma in comparison with conventional plasma platelet components Comparison of the Hemostatic efficacy of pathogen- reduced platelets vs untreated platelets in patients with thrombocytopenia and malignant hematologic diseases: a randomized clinical trial Pathogen- inactivated blood products for pediatric patients: blood safety, patient safety, or both? |
| cord-278032-27ikx97x | blood groups and vascular disease: a systematic review and metaanalysis ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? |
| cord-016815-pva22xy7 | The incidence, risk factors, and outcome of transfusion- related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case- control study Transfusion- related acute lung injury( TRALI) Fresh- frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients Transfusion- related acute lung injury Transfusion- related acute lung injury; clinical perspectives Effects of storage on effi cacy of red cell transfusion: when is it not safe? |
| cord-016815-pva22xy7 | White blood cell- reactive antibodies are undetectable in solvent/ detergent plasma Transfusion- related acute lung injury: a review Transfusion- related acute lung injury: a preventable syndrome? |
| cord-317383-uqg0xwdw | The efficacy and safety of liquid stored blood and storage duration: a confused subject; are patients confused? |
| cord-345679-ydwcp75s | The role of antibody testing for SARS- CoV-2: is there one? |
| cord-354640-5p79qpok | where do we go from here? |
| cord-018809-3nrvm4jt | Are we giving enough coagulation factors during major trauma resuscitation? |
| cord-018809-3nrvm4jt | z Where are we Heading? |
| cord-327139-u5rzp2h4 | The three- pillar matrix of patient blood management-An overview Patient blood management-A new paradigm for transfusion medicine? |
| cord-339705-x8l3zgfd | At that point if the fingerprint is as of now selecting? at that point send it to the coordinating stage in any case do the enrolment stage and store it in the database as a format. |
| cord-010772-e7kfe87q | : multicentre casecontrol study Whatʼs new in extracorporeal carbon dioxide removal for COPD? |
| cord-010772-e7kfe87q | Extracorporeal carbon dioxide removal( ECCO2R) in respiratory failure: an overview, and where next? |
| cord-344131-e7phs0jd | So why even try? |
| cord-023095-4dannjjm | ABSTRACT E-60 DOES CEFQUINOME PENETRATE THE BLOOD BRAIN BARRIER IN THE NORMAL HORSE? |
| cord-329176-av4qhu4f | Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus- infected pneumonia in wuhan, china Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
| cord-329176-av4qhu4f | Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? |
| cord-335733-u1g03s2y | Is the recommendation to use high- dose heparin for thromboprophylaxis justified? |
| cord-335733-u1g03s2y | Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19 COVID-19 and thrombotic or thromboembolic disease: implications for prevention Transport Phenomena Transport physics and biorheology in the setting of hemostasis and thrombosis ID-19? |
| cord-273388-615acz0l | The epidemic investigation on brucellosis at Wulanchabu city, Inner Mongolia Potential risk of blood transfusion- transmitted brucellosis in an endemic area of China Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T- cell lymphoma Human Tlymphotropic virus and transfusion safety: does one size fit all? |
| cord-273388-615acz0l | The potential risk of emerging infectious diseases hazarded to blood safety of China: the microbiome analysis on pooled plasma from manufactures Hepatitis E: an overview Factors in spread of hepatitis E A case of transfusion- transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food- borne route Transfusiontransmitted hepatitis E in a'nonhyperendemic'country Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area Prevention of transfusiontransmitted hepatitis E by donor- initiated self exclusion Silent hepatitis E virus infection in Dutch blood donors Novel approach for detection of hepatitis E virus infection in German blood donors Transmission of hepatitis E virus by transfusion: what is the risk? |
| cord-323906-ro078y52 | Clinical characteristics of coronavirus disease2019 in China Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? |
| cord-323906-ro078y52 | Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study COVID-19 and its implications for thrombosis and anticoagulation Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? |
| cord-323906-ro078y52 | Could anti- hypertensive drug therapy affect the clinical prognosis of hypertensive patients with COVID-19 infection? |
| cord-006226-fn7zlutj | What kind of study should be performed( e. g. cost- effectiveness, cost- utility, cost- benefit analysis)? |
| cord-006226-fn7zlutj | Which objectives should be considered? |
| cord-006226-fn7zlutj | Who should perfom a pharmacoeconomic study? |
| cord-018414-6ffhm895 | Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation A comparison of dopexamine and dopamine to prevent renal impairment in patients undergoing orthotopic liver transplantation Does aprotinin really reduce blood loss in orthotopic liver transplantation? |
| cord-018414-6ffhm895 | Living related and split donors Fast tracking in liver transplantation: which patient benefits from this approach? |
| cord-018414-6ffhm895 | Primary pulmonary hypertension and cirrhosis: are they related? |
| cord-006039-vbq9izw3 | Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990- 2013: a systematic analysis for the Global Burden of Disease Study Bad air, amulets and mosquitoes: 2,000 years of changing perspectives on malaria Mapping Plasmodium falciparum mortality in Africa between Prioritising infectious disease mapping Is Plasmodium vivax malaria a severe malaria?: |
| cord-006039-vbq9izw3 | Malaria impairs resistance to Salmonella through heme- and heme oxygenasedependent dysfunctional granulocyte mobilization A central role for free heme in the pathogenesis of severe malaria: the missing link? |
| cord-006039-vbq9izw3 | The extravascular compartment of the bone marrow: a niche for Plasmodium falciparum gametocyte maturation? |
| cord-006039-vbq9izw3 | are adhesins implicated in severe Plasmodium falciparum malaria Sequestration and tissue accumulation of human malaria parasites: can we learn anything from rodent models of malaria? |
| cord-017946-fa4ehlb0 | : is there a role for low- volume hypertonic saline resuscitation in patients managed with damage control surgery? |
| cord-017946-fa4ehlb0 | The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial Tranexamic acid in trauma: how should we use it? |
| cord-017946-fa4ehlb0 | The use of recombinant activated factor VII in platelet- associated bleeding Use of recombinant factor VIIa for adjunctive hemorrhage control in trauma and surgical patients Recombinant factor VIIa for hemorrhage control: early experience in critically ill trauma patients Recombinant factor VIIa for the treatment of severe postoperative and traumatic hemorrhage Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebocontrolled, double- blinded clinical trials Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis or pelvis and acetabulum: a double- blind, randomized, placebocontrolled trial Results of the CONTROL trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage Vasopressin in hemorrhagic shock: a systematic review and meta- analysis of randomized animal trials Vasopressin clearance and secretion during haemorrhage in normal dogs and in dogs with experimental diabetes insipidus Vasopressin and shock but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs Potential benefit of vasopressin in resuscitation of hemorrhagic shock Vasopressin deficiency in the syndrome of irreversible shock Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs Vasopressin improves survival in a porcine model of abdominal vascular injury Anti- tumor mechanisms if valproate: a novel role for an old drug Acetylation: a regulatory modification to rival phosphorylation? |
| cord-032181-gmcugd8h | : What do we really know? |
| cord-032181-gmcugd8h | The pathophysiology of trauma- induced coagulopathy Laboratory evidence of hyperfibrinolysis in association with low PAI-1 activity Interventional algorithms for the control of coagulopathic bleeding in surgical, trauma, and postpartum settings: recommendations from the Share Network Group Hyperfibrinolysis and the risk of hemorrhage in stable cirrhotic patients Does negative heparin- platelet factor 4 enzymelinked immunosorbent assay effectively exclude heparin- induced thrombocytopenia? |
| cord-032181-gmcugd8h | The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial Tranilast reduces serum IL-6 and IL-13 and protects against thioacetamide- induced acute liver injury and hepatic encephalopathy Is it worth removing albumin- bound substances in hepatic encephalopathy? |
| cord-006860-a3b8hyyr | ( platelet count< I50/~L) or a relative decrease in platelet count(? |
| cord-006860-a3b8hyyr | The examination reveals, that Fg- Au was present in a low density on the platelet surface, in higher density in the surface connected system( SCS), in coated pits and vesicles and separated smooth vesicles( representing endosomes?) |
| cord-006860-a3b8hyyr | The superpositisn of hepatitis infections on the treatment with blood and native blood products in most of the cases has let unanswered the question related to the mechanism of the immunodeficiency: the hepatitis B or C infections or the negative impact of the itarative important alloantigenlc load? |
| cord-284893-qi6dkcb3 | Chapter 40 Canada's rejection of surrogate testing How attractive does a new technology have to be to warrant adoption and utilization? |
| cord-284893-qi6dkcb3 | How should Canada fund the blood system? |
| cord-284893-qi6dkcb3 | In Performance review of Canadian blood services Safety of products Report card on Canada's blood system 7 years after the Commission of Inquiry on the blood system in Canada New variant Creutzfeldt- Jakob disease and the Canadian blood supply: Scientific basis of risk Deregulating federalism? |
| cord-284893-qi6dkcb3 | The precautionary principle and emerging biological risks: Lessons from swine flu and HIV in blood products Are all evidence- based practices alike? |
| cord-284893-qi6dkcb3 | The success of precaution? |
| cord-331289-02411gfv | A review on its molecular characteristics and role in medicine Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? |
| cord-331289-02411gfv | A single mutation in chikungunya virus affects vector specificity and epidemic potential Parvovirus transmission by blood products-a cause for concern? |
| cord-331289-02411gfv | Is the incidence and prevalence of inhibitors greater with recombinant products? |
| cord-331289-02411gfv | Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma- derived factor concentrates Human parvovirus B19 Viral pathogens Hepatitis E screening for blood donations: an urgent need? |
| cord-331289-02411gfv | Use and interpretation The reliability of HBV core antibody in serological screening for hepatitis B virus World Health Organisation( WHO) Laboratory diagnostics for hepatitis C virus infection Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatment Hepatitis C diagnostics: clinical evaluation of the HCVcore antigen determination Transfusion- transmitted hepatitis E: is screening warranted? |
| cord-291644-5y0ioety | : what's new to NO? |
| cord-291644-5y0ioety | How do red blood cells cause hypoxic vasodilation? |
| cord-291644-5y0ioety | How does spa treatment affect cardiovascular function and vascular endothelium in patients with generalized osteoarthritis? |
| cord-291644-5y0ioety | Repeated sauna therapy attenuates ventricular remodeling after myocardial infarction in rats by increasing coronary vascularity of noninfarcted myocardium Experimental investigation in rats to identify the cause of sudden death during bathing in Japan Small molecules for great solutions: Can nitric oxide- releasing nanomaterials overcome drug resistance in chemotherapy? |
| cord-291644-5y0ioety | Repeated sauna therapy increases arterial endothelial nitric oxide synthase expression and nitric oxide production in cardiomyopathic hamsters Can heat therapy help patients with heart failure? |
| cord-274061-ynqxgyw6 | Are we prepared to deal with potential threats from bioterrorism agents? |
| cord-274061-ynqxgyw6 | Does it make sense to screen all blood donations when risks of babesiosis and dengue are seasonal and geographical? |
| cord-274061-ynqxgyw6 | How much effort should be expended to prepare for an outbreak of chikungunya virus that might never happen? |
| cord-274061-ynqxgyw6 | More generally, as we become increasingly proactive in addressing infectious risks, are we misdirecting resources that could be better spent to improve blood safety in other ways? |
| cord-274061-ynqxgyw6 | What changes to the current paradigm of donor screening and testing can be considered when pathogen reduction becomes available for all blood components? |
| cord-274061-ynqxgyw6 | respiratory syndrome coronavirus in the absence of studies to establish the presence or absence of viremia in the course of the infections? |
| cord-302690-0v7ne7vi | Examples of questions asked of providers and participants to assess acceptability of the quadpill intervention Examples of questions asked of participants include:-During the trial, how easy did the participant find it to take the trial medications? |
| cord-302690-0v7ne7vi | The task force for the management of arterial 576 hypertension of the european society of hypertension( esh) and of the european society of cardiology 580 evidence- based guideline for the management of high blood pressure in adults Ambulatory blood pressure monitoring in australia: 2011 consensus position 583 statement Ambulatory blood pressure measurement: What is the international 585 consensus? |
| cord-302690-0v7ne7vi | do you consider to be important factors in patients'decisions to take blood- pressure lowering medications? |
| cord-302690-0v7ne7vi | do you think are the potential benefits of LDQT or your concerns about LDQT? |
| cord-302690-0v7ne7vi | the LDQT is available to be prescribed by participant's usual doctor, how likely would the participant be to request it? |
| cord-302690-0v7ne7vi | there any other comments the participant had about the LDQT? |
| cord-302690-0v7ne7vi | would you require to start prescribing LDQT? |
| cord-023528-z9rc0ubj | A prospective study of septicaemia in colostrum- deprived foals Care of the gut in the surgical intensive care unit: fact or fashion? |
| cord-023528-z9rc0ubj | Acute renal failure in children: aetiology and management Low- dose dopamine in the intensive care unit: DNR or DNRx? |
| cord-023528-z9rc0ubj | Endoscopic and virological observations on respiratory disease in a group of young thoroughbred horses in training Epidemiology of EHV-1 and EHV-4 in the mare and foal populations on a Hunter Valley stud farm: are mares the source of EHV-1 for unweaned foals? |
| cord-023528-z9rc0ubj | Overwhelming strongyloidosis in a foal Verminous arteritis in a 3-month- old thoroughbred foal Randomised trial of fluid restriction in ventilated very low birthweight infants Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants Hyponatraemia in children with acute CNS disease: SIADH or cerebral salt wasting? |
| cord-023528-z9rc0ubj | The protective role of gastric acidity in neonatal bacterial translocation Upper gastrointestinal tract bleeding in critically ill pediatric patients Gastric colonization as a consequence of stress ulcer prophylaxis: a prospective, randomized trial Is prophylaxis for gastric ulcers necessary in critically ill equine neonates? |
| cord-023528-z9rc0ubj | a review Clinical syndromes of gastric ulceration in foals and mature horses Gastroduodenal ulceration in foals Stress ulcer: is routine prophylaxis necessary? |
| cord-015126-cyhcbk1j | Can the regional cerebral oximetry helps us to determine individual adequate blood pressure? |
| cord-015126-cyhcbk1j | Can we achieve desired therapeutic goal in treatment of respiratory failure( RF) with this very simple, non- invasive method? |
| cord-015126-cyhcbk1j | Does diabetes mellitus matter? |
| cord-015126-cyhcbk1j | L patients died, however, hospital mortality rate was 53.8? |
| cord-015126-cyhcbk1j | Several statistical tests by the use of SPSS made it possible to analyse and answer the research question: Are children who only get long- term opioids in the initial anaesthetic phase( B) of the operation more agitated than those who where also given a refill of long- term opioids( A)? |
| cord-015126-cyhcbk1j | Table:% of positive response for each item("would you like information on this topic in an ICU booklet?") grouped into categories. |
| cord-005646-xhx9pzhj | Can HFO ce considered standard, not experimental method of therapy? |
| cord-005646-xhx9pzhj | K deficiency in earl? |
| cord-005646-xhx9pzhj | Speculation: Should not HFO be used ir pediatric patients with ARDS earlier than aggressive CMV? |
| cord-005646-xhx9pzhj | The thesis of the questionnaire was: Does the ICU syndrome occur in critical ill children in the age between three and ten, who have been intubated and/or ventilated in a PICU? |
| cord-005646-xhx9pzhj | Thunnissen t, Reinoud J.B.J. Gemke 1, Loes Veenhuizer?, Krijn Haasnoot 3, A.Johannes van Vugh0 Department of pediatrics,~Wilhelmina |
| cord-005646-xhx9pzhj | an influence of nasal mask ventilation on the REE?3.What is the nutritional state?4.What is the estimated total energy expenditure(ETE) in relation to the caloric intake? |
| cord-005646-xhx9pzhj | ~tttdy at"Ihe stale~f hematocr~ chcplm/ itic bm~ ic~ in ckil&en with 31110oN emergensy is of abviou.~!? |
| cord-005497-w81ysjf9 | ( 1) Are serum- S1P levels affected by cardiac surgery? |
| cord-005497-w81ysjf9 | ( 2) Are potential alterations of serum- S1P levels related to changes of acute- phase proteins, S1P sources or carrier? |
| cord-005497-w81ysjf9 | ( 3) Is the invasiveness of the surgery a factor that may influence serum- S1P levels? |
| cord-005497-w81ysjf9 | A hybrid approach as treatment for coronary artery disease: endo- CABG or PCI first, does it matter? |
| cord-005497-w81ysjf9 | Assessing the volume of blood taken for blood culture and culture positivitydo we need to take less blood? |
| cord-005497-w81ysjf9 | Does the endotoxin adsorption of PMX column saturate in 2 hours? |
| cord-005497-w81ysjf9 | What is the useful coagulation and fibrinolysis marker for predicting extracorporeal membrane oxygenation circuit exchange due to intra- circuit thrombus? |
| cord-022035-annn4qn1 | If the answer to( 1) is no, ask:( 3)When did you arrive in the United States, and, since your arrival, have you traveled outside the United States or Canada?" |
| cord-022035-annn4qn1 | Were you born in the United States? |
| cord-022035-annn4qn1 | A novel coronavirus associated with severe acute respiratory syndrome Faster but fast enough? |
| cord-022035-annn4qn1 | Evolution of H5N1 avian influenza viruses in Asia Probable person- to- person transmission of Avian influenza A( H5N1) Are we ready for pandemic influenza? |
| cord-022035-annn4qn1 | How can we prevent Lyme disease? |
| cord-022035-annn4qn1 | In the past 3 years, have you been outside the United States or Canada? |
| cord-022035-annn4qn1 | Responding to the epidemic of severe acute respiratory syndrome Update: Outbreak of severe acute respiratory syndrome worldwide Virology, pathology, and clinical manifestations of West Nile virus disease Westward ho? |
| cord-022035-annn4qn1 | The spread of West Nile virus Epidemiology and transmission dynamics of West Nile virus disease Guidance for industry: assessing donor suitability and blood and blood product safety in cases of known or suspected West Nile virus infection Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens West Nile Virus Surveillance: Reported to CDC as of West Nile virus window period West Nile virus among blood donors in the United States Screening the blood supply for West Nile virus RNA by nucleic amplification testing Transfusion- associated transmission of West Nile virus West Nile virus United States epidemic: the America's Blood Centers Experience Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003 Transmission of West Nile virus through blood transfusion in the United States in 2002 and investigations of West Nile virus infections in recipients of blood transfusion and organ tranplantation Insights on donor screening for West Nile virus Problem solved? |
| cord-306798-f28264k3 | A balance between clinical expression and epidemiological silence Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses Clinical features and pathobiology of Ebolavirus infection Ebola virus disease in Africa: epidemiology and nosocomial transmission Are adaptive randomised trials or non- randomised studies the best way to address the Ebola outbreak in west Africa? |
| cord-306798-f28264k3 | How can blood operators best prepare for emerging threats? |
| cord-306798-f28264k3 | The Future of Pathogen Testing? |
| cord-306798-f28264k3 | The risk- based decision- making framework Risk- based decisionmaking for blood safety: preliminary report of a consensus conference How safe is safe enough, who decides and how? |
| cord-306798-f28264k3 | WHO commends Sierra Leone for stopping Ebola virus transmission What factors might have led to the emergence of Ebola in West Africa? |
| cord-306798-f28264k3 | Why do some emerging infections impact blood safety? |
| cord-306798-f28264k3 | Why is Ebola less deadly in America than in Africa? |
| cord-009417-458rrhcm | : Is there a reason? |
| cord-009417-458rrhcm | : Preventing future occurrences: Available at Hemolytic transfusion reaction Transfusion reactions associated with anti- IgA antibodies: Report of four cases and review of the literature Febrile transfusion reaction: What blood component should be given next? |
| cord-009417-458rrhcm | A prospective study of transmission by transfusion of HTLV- I and risk factors associated with seroconversion Post- transfusion cytomegalovirus infections Reducing the risk for transfusion- transmitted cytomegalovirus infection Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? |
| cord-009417-458rrhcm | A revival for partial liquid ventilation? |
| cord-009417-458rrhcm | An in vivo evaluation of microaggregate blood fi ltration during total hip replacement Massive transfusion as a risk factor for acute lung injury: Association or causation? |
| cord-009417-458rrhcm | Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? |
| cord-009417-458rrhcm | Effect of plasma transfusions on the prothrombin time and clotting factors in liver disease Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient Fresh frozen plasma and platelet transfusion for nonbleeding patients in the intensive care unit: Benefi t or harm? |
| cord-009417-458rrhcm | Hemostasis testing during massive blood replacement: A study of 172 cases Should plasma be transfused prophylactically before invasive procedures? |
| cord-009417-458rrhcm | Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? |
| cord-009417-458rrhcm | Oxygen extraction ratio: A valid indicator of transfusion need in limited coronary vascular reserve? |
| cord-009417-458rrhcm | What does it mean clinically? |
| cord-009417-458rrhcm | Why is fresh- frozen plasma transfused? |
| cord-294684-wfsdjs1f | ( IKT) compare to other collaborative research approaches to generating and translating knowledge? |
| cord-294684-wfsdjs1f | ( IKT) evidence base: colloquium proceedings and research direction Lost in knowledge translation: time for a map? |
| cord-294684-wfsdjs1f | ; donor responsibilities Should men who have ever had sex with men be allowed to give blood? |
| cord-294684-wfsdjs1f | A systematic mapping review Developing and evaluating complex interventions: the new Medical Research Council guidance How do people become plasma and platelet donors in a VNR context? |
| cord-294684-wfsdjs1f | Are you in a mutually exclusive( monogamous) relationship? |
| cord-294684-wfsdjs1f | As of 2019, all male donors are asked'In the last 3 months, have you had sex with another man?' |
| cord-294684-wfsdjs1f | Context and social perceptions of blood donation in donors found positive for human immunodeficiency virus in France Should men who have ever had sex with men be allowed to give blood? |
| cord-294684-wfsdjs1f | Have you had sex with more than one partner in the last 3 months? |
| cord-294684-wfsdjs1f | No Is there a right to donate blood? |
| cord-294684-wfsdjs1f | The additional behavioural questions under consideration include: 1 Have you had sex with a new partner in the last 3 months? 2 |
| cord-294684-wfsdjs1f | What can qualitative research do for randomised controlled trials? |
| cord-294684-wfsdjs1f | gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100 M website views per year submit your research? |
| cord-294684-wfsdjs1f | relaxes rules for gay blood donors amid coronavirus- will Canada go further? |
| cord-294684-wfsdjs1f | the relationship between real and hypothetical moral choices An end to lifetime blood donation ban in Israel for MSM would be a major step toward a science- based policy that reduces stigma Blood donation deferral policies among men who have sex with men in Brazil Men having sex with men and blood donation: is there a game changer on the horizon? |
| cord-017248-a37t31u1 | -nasalnaturalkillerff- celi exist? |
| cord-017248-a37t31u1 | Hepatic lesions resembling alcoholic liver disease Relationship between cardiomyopathy and liver disease in chronic alcoholism Cyanamide- associated alcoholic liver disease: a sequential histologic evaluation Caroli's disease: 1977- 1995 experiences Caroli's disease and autosomal dominant polycystic kidney disease: a rare asso- ciation? |
| cord-017248-a37t31u1 | How Can One Estimate Blood Alcohol( Ethanol) Concentrations From Vitreous, Urine, or Tissue Alcohol Levels and From Alcohol in Stomach Contents? |
| cord-017248-a37t31u1 | How Can One Use Alcohol( Ethanol) Concentrations in Postmortem Specimens to Estimate the Blood Alcohol Concentration at Various Times Before Death? |
| cord-017248-a37t31u1 | How did the person( or dead body) get in the water, and 2) why could that person not get out of the water? |
| cord-017248-a37t31u1 | If under such circumstances the alcohol concentration in the vitreous was found to be 0.157 g/ dL, what was the alcohol concentration in the blood at the time of the accident? |
| cord-017248-a37t31u1 | Is There Normal"Endogenous"Blood Alcohol( Ethanol) in a Living Person? |
| cord-017248-a37t31u1 | It is not enough to ask if a person could swim but investigators should find out how well( what strokes did the victim know?) |
| cord-017248-a37t31u1 | Object( hair?) |
| cord-017248-a37t31u1 | Poisoning, Halogen( See"Fluorosis,""Poisoning, bromide,""Poisoning, chlorine or hydrochloric acid,""Poisoning, gas?, and"Poisoning, iodine!') |
| cord-017248-a37t31u1 | Sudden infantdeath syndrome( SIDS)-standardized investigations and classification: recommendations Investigation of the sudden deth of infants: a multicenter analysis Alpha l- antitrypsin deficiency- associated panniculitis: resolution with intravenous alpha I- antitrypsin administration and liver transplantation Clinical manifestations of alpha l- antitrypsin deficiency Risk of hepatobiliary disease in adults with severe alpha I- antitrypsin deficiency( PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma? |
| cord-017248-a37t31u1 | What Is the Legal Interpretation of Alcohol( Ethanol) Intoxication? |
| cord-017248-a37t31u1 | What Is the Toxicity of Alcohol Other Than Ethanol? |
| cord-023168-cd7adns8 | Are there any other treatments I should give before making the decision to transfuse, such as intravenous replacement fluids or oxygen? |
| cord-023168-cd7adns8 | Can I minimize blood loss to reduce this patient's need for transfusion? |
| cord-023168-cd7adns8 | Can hematological parameters discriminate malaria from nonmalarious acute febrile illness in the tropics? |
| cord-023168-cd7adns8 | How much time do health services spend on antenatal care? |
| cord-023168-cd7adns8 | Is it HIV TTP or HIV- associated thrombotic microangiopathy? |
| cord-023168-cd7adns8 | Plateletmediated clumping of Plasmodium falciparuminfected erythrocytes is a common adhesive phenotype and is associated with severe malaria Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation Thrombopoietin in Plasmodium falciparum malaria Immunemediated thrombo- cytopenia of malaria Thrombocytopenia in malaria: who cares? |
| cord-023168-cd7adns8 | Thalassaemia intermedia Alpha- thalssemia Hemoglobin H disease and mental retardation: a new syndrome or a remarkable coincidence? |
| cord-023168-cd7adns8 | The Thalassaemia Syndromes Pathophysiology of beta thalassaemia-a guide to molecular therapies Beta- thalassaemia intermedia: is it possible consistently to predict phenotype from genotype? |
| cord-023168-cd7adns8 | What are the risks of transmitting HIV, hepatitis, syphilis or other infectious agents through the blood products that are available for this patient? |
| cord-023168-cd7adns8 | What are the specific clinical or laboratory indications for transfusion in this patient? |
| cord-023168-cd7adns8 | What improvement in the patient's clinical condition am I aiming to achieve? |
| cord-023168-cd7adns8 | What works? |
| cord-023168-cd7adns8 | Why would the incidence of HIV- associated Hodgkin lymphoma increase in the setting of improved immunity? |
| cord-023168-cd7adns8 | can we learn and how can we help in improving diagnosis, managing patients and fostering translational research? |
| cord-023168-cd7adns8 | deficiency Importance of folate in human nutrition Review of the magnitude of folate and vitamin B 12 deficiencies worldwide Red cell or serum folate? |
| cord-023168-cd7adns8 | there models for developing countries? |
| cord-010088-s9tfvtao | 3C- S14- 01 DO WE REALLY NEED FFP? |
| cord-010088-s9tfvtao | But is this a myth? |
| cord-010088-s9tfvtao | But was the three- gene theory really wrong, when the boundaries of genes were not understood at the time? |
| cord-010088-s9tfvtao | But who decides what is false? |
| cord-010088-s9tfvtao | How can they be investigated and what should be considered? |
| cord-010088-s9tfvtao | How do I know if I have enough information to write a paper? |
| cord-010088-s9tfvtao | How has this happened? |
| cord-010088-s9tfvtao | How should my paper be put together to give it the best chance of being accepted? |
| cord-010088-s9tfvtao | If it is returned to me with comments from the reviewers, what should I do? |
| cord-010088-s9tfvtao | Is it an ATMP or non- manipulated cell product, is it a blood product or a pharmaceutical? |
| cord-010088-s9tfvtao | NEXT? |
| cord-010088-s9tfvtao | WHATS NEW WITH TRALI? |
| cord-010088-s9tfvtao | What happens to my paper after I submit it? |
| cord-010088-s9tfvtao | What is my next step if my paper is rejected, either without review or with review? |
| cord-010088-s9tfvtao | What is the value of discussing case studies? |
| cord-010088-s9tfvtao | What should be considered in different clinical situations? |
| cord-010088-s9tfvtao | Where should I try to publish the paper? |
| cord-317250-a5ni1s9e | : how are alcohol, caffeine and past smoking related to bone mineral density in elderly women? |
| cord-317250-a5ni1s9e | Alcoholic macrocytosis e is there a role for acetaldehyde and adducts? |
| cord-317250-a5ni1s9e | Clearly some do pair better than others, but transcendental experiences? |
| cord-317250-a5ni1s9e | Comparisons between Australian consumers'and industry experts'perceptions of ideal wine and cheese combinations Understanding consumer preferences for Shiraz wine and Cheddar cheese pairings Alcohol and the NIDDM patient Effect of red wine, minor constituents, and alcohol on the gastric emptying and the metabolic effects of a solid digestible meal Modulatory effect of resveratrol, a natural phytoalexin, on endothelial adhesion molecules and intracellular signal transduction Wine and resveratrol: mechanisms of cancer prevention? |
| cord-317250-a5ni1s9e | However, does the box wood or cat urine of Sauvignon blanc, the rose of Riesling, and the black currant of Cabernet Sauvignon really match with any main course? |
| cord-317250-a5ni1s9e | If some food and wine pairings are ill- conceived, are there seraphic duets? |
| cord-317250-a5ni1s9e | If supplemental knowledge were not considered to augment appreciation, why would connoisseurs be so concerned with vintage dates, wine geography, cultivars, or details of vineyard sites and wine producers? |
| cord-317250-a5ni1s9e | In addition, does the vanilla/ coconut of oak or the leather aspect of aged red wines have any inherent compatibility with food? |
| cord-317250-a5ni1s9e | Interactions between alcohol and other drugs Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies Platelet sulphotransferase activity, plasma sulfate levels, and sulphation capacity in patients with migraine and tension headache Effects of loratadine in red wineinduced symptoms and signs of rhinitis Alcohol consumption and acute myocardial infarction: a benefit of alcohol consumed with meals? |
| cord-317250-a5ni1s9e | Is ethanol a pro- drug? |
| cord-317250-a5ni1s9e | Is its only justification the reduction of undesirable aspects of the partnership and as a palate cleanser? |
| cord-317250-a5ni1s9e | Melatonin: a new bioactive compound in wine Inhibitory effects of plant phenols on the activity of selected enzymes Potential food allergens in wine: doubleblind, placebocontrolled trial and basophil activation analysis Immune response to acetaldehyde- human serum albumin adduct among healthy subjects related to alcohol intake Low prevalence of the metabolic syndrome in wine drinkers e is it the alcohol beverage or the lifestyle? |
| cord-317250-a5ni1s9e | Might not this be the most justifiable reason for the pairing most wines with food( other than reduced alcohol uptake)? |
| cord-317250-a5ni1s9e | The alcohol hangover Prolonged in vitro exposure to white wines enhances the erosive damage on human permanent teeth compared with red wines Flavonoids: antioxidants or signaling molecules? |
| cord-317250-a5ni1s9e | The effects of carbon dioxide in champagne on psychometric performance and blood- alcohol concentration Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? |
| cord-317250-a5ni1s9e | The relative antioxidant potencies of some polyphenols in grapes and wines Neurodegenerative disease and oxidative stress Type of alcoholic beverage and cancer of the oral cavity, pharynx and oesophagus in an Italian area with high wine consumption Waiter, is there histamine in my wine? |
| cord-317250-a5ni1s9e | Why ca n't Chinese Han drink alcohol? |
| cord-317250-a5ni1s9e | Without comparable tastes or flavors, where is the supposed inherent rapport between food and wine? |
| cord-317250-a5ni1s9e | compatibility or incompatibility? |
| cord-317250-a5ni1s9e | consistent observation of three urolithin phenotypes in internention trials, independent of food source, age, and health status Immunomodulatory and antitumor activities of grape seed proanthocyanidins Is dopamine behind the health benefits of red wine? |
| cord-010119-t1x9gknd | Among all potential causes investigated, only the gel card lot number was associated with the number of"?"generated( table 1). |
| cord-010119-t1x9gknd | Assuming 30 seconds of technologist time per"?", we estimate that 13.6 hours were needed to resolve and update these results. |
| cord-010119-t1x9gknd | Can Texting Decrease Wastage? |
| cord-010119-t1x9gknd | Interference: More Than Just Kell? |
| cord-010119-t1x9gknd | Is Its Use Inappropriate? |
| cord-010119-t1x9gknd | Of 19,647 columns run as part of antibody screens, 1,633( 8.3%) columns generated"? |
| cord-010119-t1x9gknd | Patient 1 was a 29 yo female, C2E2c1e1, whose RBCs reacted 11 by ECHO and 31 by NEO with anti- D4, and'?' |
| cord-010119-t1x9gknd | Platelet Rich Plasma and Quality Control: Is There a Role for the Blood Bank? |
| cord-010119-t1x9gknd | Shortly after implementation, technologists reported increased time spent performing manual resolution of indeterminate( designated as"?") results. |
| cord-010119-t1x9gknd | Study Design/ Method: We analyzed allogeneic interview responses to the screening question,"In the past 12 months have you had a tattoo?" |
| cord-010119-t1x9gknd | Study Design/ Methods: With assistance from Ortho Diagnostics, analyzer archives were queried to identify the number of gel card columns used for screens, the number of columns with"?"results, and the gel card lot numbers used for testing from 1/29/2017 to 3/31/2017. |
| cord-010119-t1x9gknd | Testing Worth the Headache? |
| cord-010119-t1x9gknd | Texas Children's Hospital, 2 Baylor College of Medicine AP127 Vision Titers--Easier or Problematic? |
| cord-010119-t1x9gknd | The Future of Plasma Therapy? |
| cord-010119-t1x9gknd | The incidence of"?"and visually negative analyzer positive results is dependent on the specific lot of MTS- Gel TM cards used. |
| cord-010119-t1x9gknd | The objective of this study was to investigate the cause of"?"and apparent false positive results on VisionV R three- cell antibody screens. |
| cord-010119-t1x9gknd | Variations in Biochemical Markers of Bone Metabolism during Plateletpheresis: Impact of Socio- Demographic and Lifestyle Factors? |
| cord-010119-t1x9gknd | Were Patients Transfused after Testing? |
| cord-010119-t1x9gknd | What Is the Best Practice for Testing Residual White Blood Cells in Blood Components for Monthly Routine Quality Control? |
| cord-010119-t1x9gknd | Where We Go? |
| cord-010092-uftc8inx | Can you confirm my genotype? cord-010092-uftc8inx Who is a blood donor recruiter?"was the topic of ABD- VII at 9- 11 March 2018. |
| cord-010092-uftc8inx | 4A- S18- 05 WHO IS SYPHILIS TESTING EXCLUDING? |
| cord-010092-uftc8inx | : IS IT TIME TO LABEL EACH UNIT WITH HB CONTENT? |
| cord-010092-uftc8inx | A donor was classified as"tired"if they responded"all the time"or"most of the time"to the question"how often do you feel that you lacked energy and strength?". |
| cord-010092-uftc8inx | ALL TOGETHER? |
| cord-010092-uftc8inx | Are we alone in the Universe? |
| cord-010092-uftc8inx | As a consequence, questions asked 30 years ago have changed: Today, molecular biologists looking at hundreds of newly discovered blood group alleles find themselves not being asked by serologists any more:"Can you confirm my serology?", but instead, pose their question to the experts for the blood group phenotype: |
| cord-010092-uftc8inx | But can we apply the metaphor as successfully into donating blood for research? |
| cord-010092-uftc8inx | Donors and Donation-Donor Adherence-are we doing the Right Thing? |
| cord-010092-uftc8inx | How can we start using this tool in unison with our existing tools to improve science and clinical practice in our respective( bio)medical fields? |
| cord-010092-uftc8inx | So is there a future for new anti- platelet agents? |
| cord-010092-uftc8inx | To evaluate self- rated health we used the well- validated single question:"How would you rate your health in general?". |
| cord-010092-uftc8inx | WHAT CAN WE LEARN FROM HOW ADVERSE EVENTS ARE DETECTED? |
| cord-010092-uftc8inx | What is the optimal balance between iron supplementation and prolongation of interdonation intervals? |
| cord-010092-uftc8inx | What then is the best approach to use? |
| cord-010092-uftc8inx | Where are we from? |
| cord-010092-uftc8inx | Where are we going? |
| cord-010092-uftc8inx | Will serologic typing be replaced by DNAbased typing? |
| cord-010092-uftc8inx | but how does this affect health? |
| cord-023346-8sqbqjm1 | ( with a selfadministered questionnaire with an open- ended question: How does blood donation affect you? |
| cord-023346-8sqbqjm1 | /socially during or after blood donation?) revealed that perceived negative effects( fatigue, diminished physical working capacity, vertigo/ dizziness, susceptibility to infections etc) |
| cord-023346-8sqbqjm1 | : will it become reality? |
| cord-023346-8sqbqjm1 | After the first 10 years with haemovigilance in the European countries, what has been the outcome of this big effort? |
| cord-023346-8sqbqjm1 | Against this background where should our attentions focus? |
| cord-023346-8sqbqjm1 | Aim: Does the interpretation of reports obtained through Outcome Review lead to an increase in the number of products per run and the overall productivity of the apheresis center? |
| cord-023346-8sqbqjm1 | An ISO standard for blood transfusion? |
| cord-023346-8sqbqjm1 | Are transfusion guidelines evidence- based? |
| cord-023346-8sqbqjm1 | Being anti- D immunoglobulin a product that has the potential risk of infection transmission, is it appropriate to use indiscriminately as a routine antenatal prophylaxis? |
| cord-023346-8sqbqjm1 | In addition, how much are we willing to pay for protection against emerging viruses? |
| cord-023346-8sqbqjm1 | Is it a mutual decision making between physician and patient? |
| cord-023346-8sqbqjm1 | Mobilization is also seen following the use of other cytokines( i.e. kit- L, Flt-3 L, IL-3) or chemokines( i.e. IL-8, Gro?), complement activation, etc., but the detailed mechanisms or the interdependence of these other pathways with the ones already proposed have not been worked out. |
| cord-023346-8sqbqjm1 | Scientific evidence to fully answer the questions'when are platelet components clinically effective'and'what do we really know?'is limited. |
| cord-023346-8sqbqjm1 | Should patients with thalassemia intermedia be regularly transfused? |
| cord-023346-8sqbqjm1 | The research theme of this questionnaire is as follows:'What is the level of knowledge and of motivation in the non- remunerated and voluntary blood donation at students?' |
| cord-023346-8sqbqjm1 | The subjects selected and debated were( i) what are the medical considerations for reducing the rate of mistransfusion? |
| cord-023346-8sqbqjm1 | These ties to industry create a tension that actually is or can be perceived as • work internationally; • send young volunteers to international youth forums; • employ young people in your organisation; Why use volunteers in blood donor recruitment? |
| cord-023346-8sqbqjm1 | We therefore resorted to developing our own model but ask the question: Why not have one international standard for blood transfusion? |
| cord-023346-8sqbqjm1 | What is however the meaning of informed consent? |
| cord-023346-8sqbqjm1 | Who cares about the quality of life of the chronic patients treated with blood products? |
| cord-023346-8sqbqjm1 | Who will hear it? |
| cord-023346-8sqbqjm1 | and( ii) what are the medical considerations for managing a limited blood inventory? |
| cord-023346-8sqbqjm1 | to apply which screening method? |
| cord-023346-8sqbqjm1 | your Trima ® can be? |
| cord-005814-ak5pq312 | * p<0.05 CAN vs NaCI? |
| cord-005814-ak5pq312 | 2) Are whole body changes in VAPCO2 and AVpH associated with parallel changes in regional circulation? |
| cord-005814-ak5pq312 | : We inquired all the nurses of the Intensive Care Unit of an Regional Hospital by an semiestructurated questionary which included personal data: age, sex, contractual relation, professional experience.., and opinion data: do you think to inform relatives is a nurse task?. |
| cord-005814-ak5pq312 | A HEROE? |
| cord-005814-ak5pq312 | A PROGNOSTIC FACTOR? |
| cord-005814-ak5pq312 | After more than 2 years clinical experience two aspects were investigated: What effort is necessary to install and support a CIS, and what is the benefit for patients and personnel on the ICU? |
| cord-005814-ak5pq312 | Are circular circuits safe? |
| cord-005814-ak5pq312 | CO, MAP, CVP, PCWP, PaO?, and Pv~ remained unchan NO administration. |
| cord-005814-ak5pq312 | Case report: A 41 year old man developed typical skin manifestations of HSP following an episode of severe( biliary?) |
| cord-005814-ak5pq312 | GS score difference seems suggestive and can be that an abnormal cerebral activity( hipofisary hormones?) may play a crucial role on onset of ARF in these patients. |
| cord-005814-ak5pq312 | In 35 patients with cardiogenic shock due to ischemic heart disease( N=26), heart failure( N=7) and valvulopathy( N=2), hemod31aamic data including measures of intravascular pressures, cardiac output and mixed venous gases were collected at regular times intervals, at least 3 times a da?. |
| cord-005814-ak5pq312 | In all 13 patients with positive blood cultures the clinical course of S, infection was complicated:? |
| cord-005814-ak5pq312 | In case ot GER persistence at the pH- metry on? |
| cord-005814-ak5pq312 | In this stud?', wc recorded the gastrointestinal motility of critically ill patients with abundant(> 250 mL/24 hours) fasting gastric aspirates. |
| cord-005814-ak5pq312 | Is there any way to individualise the triple H therapy when it is necessary? |
| cord-005814-ak5pq312 | TA Buckle? |
| cord-005814-ak5pq312 | The absence of this mechanism( right heart impairement?) |
| cord-005814-ak5pq312 | Therefore, extreme attention should be paid to the maintenance of an adequate mean arterial blood pressure( above 90 mmHg?) |
| cord-005814-ak5pq312 | We were considered that a patient had Ventilator associated pneumonia( VAP) when the specimens of Bronchoalveolar Lavage( BAL) or Protected Specimen Brush( PSI?,), ebb'ned through the bronchoscope, had one or more microorganisms in concentrations greater than 105 and 103 cfu/ ml respectively. |
| cord-005814-ak5pq312 | Where are we?. |
| cord-005814-ak5pq312 | Which of the next informafions do you think is more important? |
| cord-005814-ak5pq312 | and AVpH also reflect the onset of tissue hypoxia during endotoxemia? |
| cord-005814-ak5pq312 | thrombolytic therapy or pulmonary embolectomy? |
| cord-023364-ut56gczm | ( with a selfadministered questionnaire with an open- ended question: How does blood donation affect you? |
| cord-023364-ut56gczm | /socially during or after blood donation?) revealed that perceived negative effects( fatigue, diminished physical working capacity, vertigo/ dizziness, susceptibility to infections etc) |
| cord-023364-ut56gczm | : will it become reality? |
| cord-023364-ut56gczm | After the first 10 years with haemovigilance in the European countries, what has been the outcome of this big effort? |
| cord-023364-ut56gczm | Against this background where should our attentions focus? |
| cord-023364-ut56gczm | Aim: Does the interpretation of reports obtained through Outcome Review lead to an increase in the number of products per run and the overall productivity of the apheresis center? |
| cord-023364-ut56gczm | An ISO standard for blood transfusion? |
| cord-023364-ut56gczm | Are transfusion guidelines evidence- based? |
| cord-023364-ut56gczm | Being anti- D immunoglobulin a product that has the potential risk of infection transmission, is it appropriate to use indiscriminately as a routine antenatal prophylaxis? |
| cord-023364-ut56gczm | In addition, how much are we willing to pay for protection against emerging viruses? |
| cord-023364-ut56gczm | Is it a mutual decision making between physician and patient? |
| cord-023364-ut56gczm | Mobilization is also seen following the use of other cytokines( i.e. kit- L, Flt-3 L, IL-3) or chemokines( i.e. IL-8, Gro?), complement activation, etc., but the detailed mechanisms or the interdependence of these other pathways with the ones already proposed have not been worked out. |
| cord-023364-ut56gczm | Scientific evidence to fully answer the questions'when are platelet components clinically effective'and'what do we really know?'is limited. |
| cord-023364-ut56gczm | Should patients with thalassemia intermedia be regularly transfused? |
| cord-023364-ut56gczm | The research theme of this questionnaire is as follows:'What is the level of knowledge and of motivation in the non- remunerated and voluntary blood donation at students?' |
| cord-023364-ut56gczm | The subjects selected and debated were( i) what are the medical considerations for reducing the rate of mistransfusion? |
| cord-023364-ut56gczm | These ties to industry create a tension that actually is or can be perceived as • work internationally; • send young volunteers to international youth forums; • employ young people in your organisation; Why use volunteers in blood donor recruitment? |
| cord-023364-ut56gczm | We therefore resorted to developing our own model but ask the question: Why not have one international standard for blood transfusion? |
| cord-023364-ut56gczm | What is however the meaning of informed consent? |
| cord-023364-ut56gczm | Who cares about the quality of life of the chronic patients treated with blood products? |
| cord-023364-ut56gczm | Who will hear it? |
| cord-023364-ut56gczm | and( ii) what are the medical considerations for managing a limited blood inventory? |
| cord-023364-ut56gczm | to apply which screening method? |
| cord-023364-ut56gczm | your Trima ® can be? |
| cord-023354-f2ciho6o | ( with a selfadministered questionnaire with an open- ended question: How does blood donation affect you? |
| cord-023354-f2ciho6o | /socially during or after blood donation?) revealed that perceived negative effects( fatigue, diminished physical working capacity, vertigo/ dizziness, susceptibility to infections etc) |
| cord-023354-f2ciho6o | : will it become reality? |
| cord-023354-f2ciho6o | After the first 10 years with haemovigilance in the European countries, what has been the outcome of this big effort? |
| cord-023354-f2ciho6o | Against this background where should our attentions focus? |
| cord-023354-f2ciho6o | Aim: Does the interpretation of reports obtained through Outcome Review lead to an increase in the number of products per run and the overall productivity of the apheresis center? |
| cord-023354-f2ciho6o | An ISO standard for blood transfusion? |
| cord-023354-f2ciho6o | Are transfusion guidelines evidence- based? |
| cord-023354-f2ciho6o | Being anti- D immunoglobulin a product that has the potential risk of infection transmission, is it appropriate to use indiscriminately as a routine antenatal prophylaxis? |
| cord-023354-f2ciho6o | In addition, how much are we willing to pay for protection against emerging viruses? |
| cord-023354-f2ciho6o | Is it a mutual decision making between physician and patient? |
| cord-023354-f2ciho6o | Mobilization is also seen following the use of other cytokines( i.e. kit- L, Flt-3 L, IL-3) or chemokines( i.e. IL-8, Gro?), complement activation, etc., but the detailed mechanisms or the interdependence of these other pathways with the ones already proposed have not been worked out. |
| cord-023354-f2ciho6o | Scientific evidence to fully answer the questions'when are platelet components clinically effective'and'what do we really know?'is limited. |
| cord-023354-f2ciho6o | Should patients with thalassemia intermedia be regularly transfused? |
| cord-023354-f2ciho6o | The research theme of this questionnaire is as follows:'What is the level of knowledge and of motivation in the non- remunerated and voluntary blood donation at students?' |
| cord-023354-f2ciho6o | The subjects selected and debated were( i) what are the medical considerations for reducing the rate of mistransfusion? |
| cord-023354-f2ciho6o | These ties to industry create a tension that actually is or can be perceived as • work internationally; • send young volunteers to international youth forums; • employ young people in your organisation; Why use volunteers in blood donor recruitment? |
| cord-023354-f2ciho6o | We therefore resorted to developing our own model but ask the question: Why not have one international standard for blood transfusion? |
| cord-023354-f2ciho6o | What is however the meaning of informed consent? |
| cord-023354-f2ciho6o | Who cares about the quality of life of the chronic patients treated with blood products? |
| cord-023354-f2ciho6o | Who will hear it? |
| cord-023354-f2ciho6o | and( ii) what are the medical considerations for managing a limited blood inventory? |
| cord-023354-f2ciho6o | to apply which screening method? |
| cord-023354-f2ciho6o | your Trima ® can be? |
| cord-015021-pol2qm74 | ( 3) Should future clinical trials be based on new classifications of illness such as MODS, SIRS, APACHE III, SAP II, MRM, etc., or should trials be dedicated to specific diseases-urinary tract infections, pneumonia, trauma patients, cardiac surgery and other specific problems, rather than generalized problems of sepsis, the sepsis syndrome and other classifications? |
| cord-015021-pol2qm74 | 3-Is the ACCP classification of sepsis useful at the bedside to select oatients? |
| cord-015021-pol2qm74 | Abnormally high skeletal muscle pO 2 in septic patients and its normalization during recovery: Evidence against tissue hypoxia but for impaired oxygen metabolism of skeletal muscle? |
| cord-015021-pol2qm74 | Administration of exogenous IFN? |
| cord-015021-pol2qm74 | And, finally, how can the participants be sure that the trial will be stopped at the right time, to ensure that no treatment is given to any patient that might be harmful? |
| cord-015021-pol2qm74 | Are all eligible patients being studied, and their results reported? |
| cord-015021-pol2qm74 | Are all the participants truly unbiased about the relative merits of the regimens being studied? |
| cord-015021-pol2qm74 | Before using the model for risk of death in septic patients, is it mandatory to validate it( by calibration, i.e. goodness of fit, and discrin'dnation, i.e., ROC curves) first on a data base using the same definition for sepsis as in the trial and secondly on the placebo group of the trial? |
| cord-015021-pol2qm74 | Can it achives a significant improvement in the septic course, organ dysfunction, and final outcome? |
| cord-015021-pol2qm74 | Conversely, administration of anti- IFN? |
| cord-015021-pol2qm74 | Correlatively the RNI inhibitor MMLA induces in vitro a decrease in the rate of bacterial killing, fxom 78% to 57%, in macrophages triggered with IFN-?+ LPS. |
| cord-015021-pol2qm74 | How can organ dysfunction and/or failure be defined? |
| cord-015021-pol2qm74 | How should we decide which of them should be brought to clinical trial? |
| cord-015021-pol2qm74 | If there is agreement that thin is an appropriate antibiotic protocol, should it not be used in all seriously ill septic patients in the hospital? |
| cord-015021-pol2qm74 | In contrast, GF109203X significantly reduced ICAM-1 expression induced by Interferon- y( IFN-?) |
| cord-015021-pol2qm74 | In fact, the IFN-? and IL-1 induced adhesion of PBMC to cytokine treated HUVEC could be downregulated by the PKC- inhibitor, whereas TNFc~-and LPS- mediated adhesion was not influenced. |
| cord-015021-pol2qm74 | In other words, should we now begin to have clinical trials on specific diseases with causes that are known and can be attacked? |
| cord-015021-pol2qm74 | Interferon-? |
| cord-015021-pol2qm74 | Is like being compared with like-are all the end points and the standards for measuring them clearly defined so that they can not be misunderstood? |
| cord-015021-pol2qm74 | Is there any role for antioxidative therapy in sepsis? |
| cord-015021-pol2qm74 | Is truly informed consent being sought that will satisfy not only the patient's right to choose what happens to him, but also the law of the land? |
| cord-015021-pol2qm74 | MIF secretion also was induced by TNFoc( 1 ng/ ml) and IFN? |
| cord-015021-pol2qm74 | MIF secretion is induced by LPS, TNFc~ and IFN?. |
| cord-015021-pol2qm74 | Macrophages of C57BL/10ScCr mice are incapable of producing interferon-~( IFN~) which we could show to be obligatory for the production of IFN? |
| cord-015021-pol2qm74 | On closer investigation the impaired IFN? |
| cord-015021-pol2qm74 | The IFN? |
| cord-015021-pol2qm74 | The absence of sensitization to LPS in Lps d C57BL/10ScCr mice was identified as being due to their inability to produce interferon-7( IFN?). |
| cord-015021-pol2qm74 | The clinical"take"rate o? cultured epithelial autografts( CEA) has been observed to Increase with transplantation to allodermls, but the reasons for the improved clinical performance have not yet been defined. |
| cord-015021-pol2qm74 | The inability to produce adequate amounts of IL-2, most likely attributable to alterations in the transmission of signals from the cell membrane to the nucleus, results in incomplete proliferative T- cell responses to antigenic stimuli, while a lack of? |
| cord-015021-pol2qm74 | There are reports of nentrophil dysfunction in inflammatory disorders of the skin( 2), Are there dysfunctions concerning the unspecific host defense in SIRS, as well? |
| cord-015021-pol2qm74 | This has not happened, however, and the question is"Why not"? |
| cord-015021-pol2qm74 | This might be due to a preexisting( genetic?) or more likely to an epiphenomenal receptor defect. |
| cord-015021-pol2qm74 | We have investigated the proinflaznmatory oytokine secretion patter~ by PMN in patients following major~hermal or tra~ matic injury and in volunteers fellowinq endotoxemia.? |
| cord-015021-pol2qm74 | What are the definitions? |
| cord-015021-pol2qm74 | What are the issues, then, in 1994, to be dealt with at this symposium and congress? |
| cord-015021-pol2qm74 | What are the mechanisms? |
| cord-015021-pol2qm74 | What is the aplpiieability of study results in typical clinical situations? |
| cord-015021-pol2qm74 | What is the availability of speciftc antibiotics at a participating hospital? |
| cord-015021-pol2qm74 | Will the patient's physicians agree to the protocol choice? |
| cord-015021-pol2qm74 | Will they be helpful in the study and esro of patients? |
| cord-015021-pol2qm74 | Will this contribute to better clinical trials, information basis and better research? |
| cord-015021-pol2qm74 | Will we benefit Oleo from a more precise classification and definition of a non- outjty, a hodgu- podge of human disorders which have charsmeristic.s and manifestations of tissue injury, inflammation and infactian? |
| cord-015021-pol2qm74 | and?-IFN and T- helper-2( Th2) acting principally in inducing antibody formation with a secretion of IL-4, IL-5, IL-10 and TNF-[3 has still to be established within the context of major trauma. |
| cord-015021-pol2qm74 | anti- IFN-?( p<0.05). |
| cord-015021-pol2qm74 | or is it better to use a specific model for each trial? |
| cord-015021-pol2qm74 | ~is s?. |
| cord-026031-hnf5vayd | Any cleaning products used inside or outside the house within the last 48 hours? |
| cord-026031-hnf5vayd | Any construction work or renovation recently? |
| cord-026031-hnf5vayd | Any fertilizers or weed killer used in the last week? |
| cord-026031-hnf5vayd | Any mouse or rat poison in your house, yard, or garage? |
| cord-026031-hnf5vayd | Are there any abnormal postures? |
| cord-026031-hnf5vayd | Are there any characteristic odors on the breath? |
| cord-026031-hnf5vayd | Are there any other abnormal signs that you have seen? |
| cord-026031-hnf5vayd | Are there any pulse deficits or dysrhythmias auscultated? |
| cord-026031-hnf5vayd | Are there any traces of foreign material on the tongue or in the crevices of the teeth or gums? |
| cord-026031-hnf5vayd | Are there petechiae or ecchymosis on the gums or bleeding from the gumline? |
| cord-026031-hnf5vayd | Did the owner attempt any irrigation or medical techniques prior to presentation? |
| cord-026031-hnf5vayd | Did you give any medications to your animal? |
| cord-026031-hnf5vayd | Did you witness the ingestion or exposure? |
| cord-026031-hnf5vayd | Did your pet eat this morning or last night? |
| cord-026031-hnf5vayd | Do the intestinal loops feel normal, or are they fluid- filled or gas- filled? |
| cord-026031-hnf5vayd | Do you have any over- the- counter or prescription medications that your animal may have had access to? |
| cord-026031-hnf5vayd | Do you have the container with you today? |
| cord-026031-hnf5vayd | Do you hear harsh airway sounds or pulmonary crackles? |
| cord-026031-hnf5vayd | Do you observe any ptyalism or attempts to vomit? |
| cord-026031-hnf5vayd | Do you think that the signs have been the same, better, or getting worse? |
| cord-026031-hnf5vayd | Does it appear lethargic or hyperactive? |
| cord-026031-hnf5vayd | Does the animal have access to any poisonous substances? |
| cord-026031-hnf5vayd | Does your animal have access to any known toxins, or does he or she run loose unattended? |
| cord-026031-hnf5vayd | Does your animal have any ongoing or past medical problems? |
| cord-026031-hnf5vayd | Does your animal run loose outdoors unattended? |
| cord-026031-hnf5vayd | Does your pet have access to a compost pile? |
| cord-026031-hnf5vayd | Does your pet have access to neighboring properties( even for a short time)? |
| cord-026031-hnf5vayd | Does your pet run loose unattended? |
| cord-026031-hnf5vayd | For example, is the patient retaining bicarbonate( metabolic alkalosis) because of carbon dioxide retention( respiratory acidosis)? |
| cord-026031-hnf5vayd | Has it changed at all since the owner noticed the problem? |
| cord-026031-hnf5vayd | Has there been any gardening work recently? |
| cord-026031-hnf5vayd | Has there been any prior incident of ocular disease? |
| cord-026031-hnf5vayd | Has your animal been on any medications recently or currently? |
| cord-026031-hnf5vayd | Has your animal been vaccinated recently? |
| cord-026031-hnf5vayd | Has your animal had any previous or similar episodes? |
| cord-026031-hnf5vayd | Has your pet been off your property in the last 24- 48 hours? |
| cord-026031-hnf5vayd | Has your pet been to rural areas in the last week? |
| cord-026031-hnf5vayd | Has your pet had any antiflea/ tick medication within the last week?Your pet's environment Is your animal kept inside or outside of the house? |
| cord-026031-hnf5vayd | Has your pet traveled outside of your immediate geographic location? |
| cord-026031-hnf5vayd | Have any known relatives of your animal had any bleeding disorders? |
| cord-026031-hnf5vayd | Have similar signs occurred in the past? |
| cord-026031-hnf5vayd | Have the signs become better or worse since you first saw them? |
| cord-026031-hnf5vayd | Have you changed your radiator fluid or does a car leak antifreeze? |
| cord-026031-hnf5vayd | Have you fed table scraps or anything new recently? |
| cord-026031-hnf5vayd | How fast did the clinical signs develop? |
| cord-026031-hnf5vayd | How is the patient acting? |
| cord-026031-hnf5vayd | How long ago do you think that your pet was exposed to the poison? |
| cord-026031-hnf5vayd | How long ago was the exposure? |
| cord-026031-hnf5vayd | How long has the animal been acting that way? |
| cord-026031-hnf5vayd | How much did the animal consume? |
| cord-026031-hnf5vayd | How soon did other signs develop? |
| cord-026031-hnf5vayd | If so, what? |
| cord-026031-hnf5vayd | If so, when and how much did your animal consume? |
| cord-026031-hnf5vayd | If so, when? |
| cord-026031-hnf5vayd | If so, which? |
| cord-026031-hnf5vayd | Is abdominal palpation painful? |
| cord-026031-hnf5vayd | Is it a liquid concentrate, dilute spray, or solid? |
| cord-026031-hnf5vayd | Is it fast, normal, or slow? |
| cord-026031-hnf5vayd | Is it moist, dry, bubbling, or frothy, or caked with dirt? |
| cord-026031-hnf5vayd | Is it normal and pink, or dark red( injected), pale, or icteric? |
| cord-026031-hnf5vayd | Is it normal, fast, shallow, or labored? |
| cord-026031-hnf5vayd | Is it synchronous with the heart rate, or are there dropped pulses? |
| cord-026031-hnf5vayd | Is the animal ambulatory, and if so, do you observe any gait abnormalities? |
| cord-026031-hnf5vayd | Is the lens clear and is it in the normal position? |
| cord-026031-hnf5vayd | Is the ocular examination normal? |
| cord-026031-hnf5vayd | Is the pulse bounding, normal, thready, or not palpable? |
| cord-026031-hnf5vayd | Is there a P wave for every QRS, and a QRS for every P wave? |
| cord-026031-hnf5vayd | Is there a chance that your pet may have gotten into the garbage? |
| cord-026031-hnf5vayd | Is there a palpable urinary bladder? |
| cord-026031-hnf5vayd | Is there any history of trauma or known chemical irritant or exposure? |
| cord-026031-hnf5vayd | Is there any possibility of any toxin exposure? |
| cord-026031-hnf5vayd | Is there any possibility of trauma? |
| cord-026031-hnf5vayd | Is there any vomiting, diarrhea, trembling, or seizures? |
| cord-026031-hnf5vayd | Is there evidence of vomiting or diarrhea? |
| cord-026031-hnf5vayd | Is there excessive salivation? |
| cord-026031-hnf5vayd | Is there respiratory distress? |
| cord-026031-hnf5vayd | Is there urine production? |
| cord-026031-hnf5vayd | Is your animal able to walk? |
| cord-026031-hnf5vayd | Is your animal breathing or does it have respiratory difficulty? |
| cord-026031-hnf5vayd | Is your pet kept in a fenced- in yard or allowed to run loose unattended? |
| cord-026031-hnf5vayd | It is useful to phrase questions in a neutral fashion- for example,"Is such- and- such present on the premises?" |
| cord-026031-hnf5vayd | Was the substance swallowed, or is it on the animal's skin or eyes? |
| cord-026031-hnf5vayd | What clinical signs developed? |
| cord-026031-hnf5vayd | What do you hear on thoracic auscultation? |
| cord-026031-hnf5vayd | What is the animal's activity level? |
| cord-026031-hnf5vayd | What is the capillary refill time? |
| cord-026031-hnf5vayd | What is the color and consistency of the feces? |
| cord-026031-hnf5vayd | What is the color of the gums or tongue? |
| cord-026031-hnf5vayd | What is the color of the urine? |
| cord-026031-hnf5vayd | What is the mucous membrane color? |
| cord-026031-hnf5vayd | What is the name of the product? |
| cord-026031-hnf5vayd | What is the nature of the bleeding? |
| cord-026031-hnf5vayd | What is the patient's blood pressure? |
| cord-026031-hnf5vayd | What is the patient's electrocardiogram? |
| cord-026031-hnf5vayd | What is the patient's heart rate? |
| cord-026031-hnf5vayd | What is the patient's rectal temperature? |
| cord-026031-hnf5vayd | What is the patient's respiratory character? |
| cord-026031-hnf5vayd | What is the patient's respiratory rate? |
| cord-026031-hnf5vayd | What is the pupil reactivity to light? |
| cord-026031-hnf5vayd | What is the pupil size? |
| cord-026031-hnf5vayd | What is the quality of the femoral pulse? |
| cord-026031-hnf5vayd | What is the sensitivity to light or sound? |
| cord-026031-hnf5vayd | What is the substance that your animal ingested( was exposed to)? |
| cord-026031-hnf5vayd | What is your chief complaint or reason that you brought your animal in on emergency? |
| cord-026031-hnf5vayd | What other conditions have developed and what are they? |
| cord-026031-hnf5vayd | What sites are affected? |
| cord-026031-hnf5vayd | What was the first abnormal sign noticed? |
| cord-026031-hnf5vayd | When did the signs first start, or when was your animal last normal? |
| cord-026031-hnf5vayd | When did you first notice that something was wrong with your pet? |
| cord-026031-hnf5vayd | When was the animal last seen as normal? |
| cord-026031-hnf5vayd | When was the last time you noticed your pet act normally? |
| cord-026031-hnf5vayd | When was the onset of clinical signs? |
| cord-026031-hnf5vayd | When was the problem first noticed? |
| cord-026031-hnf5vayd | Where do you think it happened? |
| cord-026031-hnf5vayd | Where has your pet been in the last 24 hours? |
| cord-026031-hnf5vayd | if so, where? |
| cord-026031-hnf5vayd | or When was the last time you saw your animal act normally? |
| cord-026031-hnf5vayd | rather than"Could the dog have eaten such- and- such?" |
| cord-026031-hnf5vayd | she normally fed? |
| cord-026031-hnf5vayd | • How long has the bleeding been going on? |